European Journal of Rheumatology
Case Report

Refractory anemia in systemic sclerosis: myelodisplastic syndrome

1.

Department of Rheumatology,Adnan Menderes University Faculty of Medicine, Aydın, Turkey

2.

Department of Hematology, Adnan Menderes University Faculty of Medicine, Aydın, Turkey

Eur J Rheumatol 2015; 2: 120-121
DOI: 10.5152/eurjrheum.2015.0100
Read: 208 Downloads: 45 Published: 03 September 2019

Abstract

Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by small vessel vasculopathy, autoantibodies, and skin or visceral organ fibrosis (lung, oesophagus, kidney etc.) as a result of extracellular collagen deposition. The cancer risk is higher in many rheumatic diseases, including SSc. Various defined malignancies may develop in 3%-11% of patients with SSc. These solid tumors are generally observed in the lung, oesophagus, or breast. In addition, an increased risk for hematological cancers were reported in literature. Herein, we describe an interesting case of SSc complicated by myelodisplastic syndrome (MDS). Our aim is to draw attention to developing cancers and the rare occurence of MDS in patients with SSc. 

Files
ISSN2147-9720 EISSN 2148-4279